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Introduction
The CpG dinucleotide is unique for its ability to carry both 
genetic and epigenetic information in the genome of a differ-
entiated mammalian cell.1,2 Variation in DNA methylation, 
facilitated by this two base pair motif, influences gene expres-
sion, and thereby enables tissue-specific function.3-6 However, 
this dinucleotide is substantially depleted, to one fifth of the 
expected level, due to the hypermutability (~11-fold) of cytosines 
when methylated.7-9 Yet, a minority of CpGs is retained against 
this strong tide of loss by a variable combination of: evasion of 
methylation in the germline, functional importance or chance. 
These are predominantly in CpG dense regions.10 Additionally, 
new CpGs are created by mutation through base substitution and 
as a by-product of the increase of GC in regions of biased gene 
conversion (BGC).11
A high density region of unmethylated CpGs can recruit CpG 
binding proteins, such as Cfp1 and KDM2A, which modify his-
tone tails.12,13 Thomson et al. have shown that the experimental 
inclusion of a cluster of unmethylated CpGs is sufficient to estab-
lish domains of H3K4me3.12 This histone modification leads to 
genomic three-dimensional structure change and the acquisition 
of permissive chromatin regions within the expanse of repressed 
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genome.14 CpG clusters, termed CpG Islands (CGIs), co-locate 
with 60–70% of human gene promoters, often those of house-
keeping genes that are hypomethylated in the germ line,15,16 but 
also 40% that are tissue-specific.10,17 Methylation of CGI pro-
moters acts as a durable silencing mechanism. However, the 
majority of CGIs are unmethylated in differentiated cells inde-
pendently of their transcriptional activity.10,18 The methylation 
state of CGI is strongly correlated with its CpG content, with 
high density CGIs being predominately constitutively unmeth-
ylated and “weak” low density islands the preferred target for 
tissue-specific methylation.10,19 CpG gain that shifts an island 
from weak to strong status therefore affects its dynamic ability 
for methylation change.
CpGs located in the lower density regions surrounding 
islands, termed CpG shores (~2 kb up- or down-stream), identify 
significant tissue-, cancer- and reprogramming-specific methyla-
tion variability.6,20-22 Therefore, shore accretion and island ero-
sion by subtle modulation in CpG density within these regions 
may have a disproportionate influence on the methylation levels 
and locations of these flanking regions. Additionally, an increase 
in methylation variance has been proposed to have an evolution-
ary important role, as well as being a potential influence on dis-
ease susceptibility.23
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performed by examining the Enredo-Pecan-Ortheus Whole-
Genome Multiple Alignments Sequences for human, chimpan-
zee, gorilla, orang-utan, rhesus macaque and common marmoset 
(Ensembl Compara.6_primates_EPO).51,52 This set of sequences 
contains 19,198 blocks and has been able to align 84.54% of the 
human genome. We parsed the blocks of this alignment requir-
ing non-duplicated sequence in both human and chimpanzee 
and sequence of at least one other primate, which reduced our 
quasi-genomic set (referred to as h1c1o1: human, chimpanzee 
and other primate) to 79.99% of the human genome. This con-
tained 25,100,205 or ~88.95% of the total haploid human CpGs. 
Each of these remaining CpGs was then interrogated with the 
requirement that at its precise position none of the other primates 
had a CpG dinucleotide present. Furthermore the chimpanzee 
sequence and the closest nearest other primate present in the 
alignment block (96.6% Gorilla) were required to have aligned 
sequence at this position i.e. was not N or -. This led to an ini-
tial human-specific subset of 1,820,319 CpGs. These CpGs were 
then conservatively filtered for polymorphism utilizing 1,000 
genomes data removing any CpG with any evidence of variation, 
as a SNP, or within a copy number or structural variant,53 leading 
to a final estimate of 1,192,484 human-specific CpGs.
CpG beacons. We define “beacons” as species-specific non-
polymorphic DNA motifs able to carry both genetic and epigen-
etic information. According to the above analysis, we estimated 
the number of CpG beacons to be ~1.19 million in the human 
genome. In the future a definitive set will be able to be established 
following mass whole genome sequencing in a large number of 
these primates. However this current calculation will already 
be enriched for “true” human CpG beacons that can facilitate 
unique species-specific epigenomic variation. A user interface to 
view the human CpG beacons in the UCSC genome browser in 
the context of existing annotation is available at www2.cancer.
ucl.ac.uk/medicalgenomics/humanCpGBeacons/trackList.php.
The density distribution of the human beacons in 1 kb win-
dows was estimated, which showed more than half were single-
tons, ~2% were ≥ 5 beacons/kb, and 0.03% were ≥ 20 beacons/
kb. To assess the significance of this long tail with higher density, 
we performed 1,000 permutations by choosing a set of random 
beacons from the CpG locations in the h1c1o1 genomic set. This 
simulation never exceeded the number of peaks that are ≥ 20 
CpG beacons/kb in the observed genome set (peaks ≥ 20 CpG 
beacons/kb: simulation peaks range = 0–7, simulation aver-
age = 1.527 peak per genome, observed peaks = 21, empirical 
p < 1 × 10-3).
Extreme CpG beacon clusters. Taking this ≥ 20 CpG bea-
cons/kb as an initial threshold (which reflects an increase of 
≥ 4% in CpG density per kb in human compared with the other 
primates) we identified 21 extreme genomic outliers of human 
CpG beacon density (see Table S1). Beacon density distribution 
is displayed across the genome in Figure 1. This initial observa-
tion revealed that the third highest peak on Chromosome 20 co-
located with the promoter CGI of the HAR1A gene, a non-coding 
gene significant in cortical development discovered by Pollard 
et al. (Fig. S1).32 HAR1A was identified to be co-expressed by 
Cajal-Retzius neurons, with Reelin, a secreted glycoprotein that 
The genetic loss and gain of CpG dinucleotides over evolution-
ary time will impact upon the epigenome. Genome-wide variation 
in GC content at the megabase scale led to the formation of iso-
chores before mammalian radiation24,25 with an increase in CpGs 
occurring ~90 million years ago (MYA).26 A subsequent clock-like 
loss of CpGs, due to the time- not generation-dependent substitu-
tion rate of cytosine deamination,27 has led to roughly similarly 
numbered, but differing sets of CpGs in primates. The mutabil-
ity of individual CpGs can be determined by accounting for the 
influence of surrounding CpG density, as well as by sequence con-
text and nucleosome position.28,29 Regions of CpGs that remain 
hyperconserved have been found to co-locate with polycomb 
repressive complex 2 binding domains and developmental genes.28
On the other hand, GC increase is influenced by primate 
recombination rates.30,31 So much so, that regions of extreme 
substitutional divergence in the human genome32-34 co-locate 
with recombination-associated BGC.35-39 This process therefore 
negates or obscures any potential evidence of weak selection.39,40 
BGC can lead to the formation of CGIs11 and, furthermore, 
Cohen et al. have recently shown that CGIs can evolve without 
the requirement of selective pressure,41 although a possible subtle 
influence on CpGs via gene body methylation may exist.42
Cytosine deamination is consequently the predominant single 
nucleotide mutational force, occurring at one order of magni-
tude higher in the genome than other single base substitutions. 
Conversely, a highly localized BGC-mediated increase of CpGs 
occurs, associated with recombination.36,40 To discover the loca-
tions of potential species-specific regulatory modulation, due to 
CpG dinucleotide change, we identified a subset of human CpGs 
that were only present, either uniquely maintained or gained, in 
that lineage. While there are approximately ~40 million genetic 
differences between human and chimpanzee, the vast major-
ity are due to random genetic drift.43 Divergence at CpG sites 
between these two species is estimated to be at 15.2%, compared 
with 0.92% for other nucleotide substitutions.43 Therefore, we 
used the additive collective power of multiple closely related spe-
cies in a six-species inter-primate comparison.44,45
The CpG sequence can itself act as a genomic signaling mol-
ecule via combinatorial transcription factor binding specificity,1,46 
facilitate epigenomic variation by influencing CGI promoter 
amenable chromatin structure and gene body methylation.47,48 
Consequently we hypothesized that by identifying human- 
specific CpGs we may find potential regions of species- 
specific differential regulation.5,42,49,50 The sequence comparative 
approach would be blind to any potential causative mechanisms. 
The novel CpG clusters identified may highlight genes where a 
species-specific shift in epigenetic control has been enabled by 
this genetic change. These regions would potentially be enriched 
for human traits, as well as the possibility of associations with 
disease susceptibilities that have arisen as a by-product of human 
evolution.
Results
Human-Specific CpGs. To uncover the subset of CpGs pres-
ent only in the human lineage, an inter-primate comparison was 
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transmission (SYT163); as well as total cerebral brain volume in a 
radiological examination (CDH464) (see Table S1). To take into 
consideration any possible gene size bias, we also performed an 
analysis using the regional based binomial test included in the 
GREAT gene enrichment analysis tool65 (using default cut-offs 
but reducing the maximum distal extension from 1 Mb to 100 kb, 
see methods) for these 20 CpG beacon clusters, excluding the 
known HAR1A result. This was significant for only three catego-
ries of biological process with an FDR Q ≤ 0.15: which included 
the categories cognition (binomial raw p = 1.43 × 10-5, FDR 
Q = 1.26 × 10-1), and behavior (binomial raw p = 2.25 × 10-5, 
FDR Q = 9.87 × 10-2). Furthermore, as a negative control, we also 
calculated the locations of the Chimpanzee CpG beacon clusters 
that exceed the 20/kb threshold and these identified no genes 
implicated with developmental delay or mental retardation (see 
Table S2) and as well was non-significant with GREAT analysis 
(via liftOver to human).
The human CpG beacon clusters represent regions of poten-
tial regulatory modulation or change to the nearby genes that is 
human-specific. This correlation, and not causation within these 
regions, is of interest particularly as these monogenic disease 
genes have shown that genetic mutation within them is not lethal 
but carries significant developmental and neurological pathology. 
These important genes could therefore be the plausible targets of 
significant regulatory change between human and other closely 
related primates due to the similarity of their proteomes.66
Biased-gene conversion overlap. The human extreme beacon 
clusters showed very strong overlap with the top 200 regions of 
BGC identified by Drezser et al. (57.1% of ≥ 20 CpG beacons/
kb clusters, χ2 p < 2.20 × 10-16),36 thus implicating localized GC 
is fundamental in specifying the six-layer structure of human 
cortex.32 This gene had been first identified by mammalian and 
vertebrate comparative genomics for regions of high conservation 
but outlying substitution of any type in the human genome, with 
an extreme region of 118 bp containing 18 human changes since 
the Homo-Pan split. In fact eight of these substitutions are CpG 
beacon creating, from the total of 35 in this cluster that spans 
~1.8 kb. This locus would still be a genomic CpG beacon cluster 
outlier with a peak of 24/kb even with this 118bp region removed. 
Therefore this critical non-coding gene was able to be identified 
without any recourse to longstanding vertebrate or mammalian 
conservation but purely by focusing on inter-primate CpG den-
sity change. Larger regions of bias identified across this locus have 
implicated recombination hotspot drift over time.38,54
We were therefore interested in the significance of the other 
20 CpG beacon clusters identified in the human genome. We 
preformed gene set enrichment with Ingenuity Pathway Analysis 
(IPA, ©2011 Ingenuity Systems, Inc.) on these genes overlap-
ping an extreme beacon cluster (70%), or within 100 kb 5' or 
50 kb 3' of their transcript, and found highest significant enrich-
ment for the categories of developmental and genetic disorder, 
inflammatory response, reproductive system development and 
function, and neurological disease genes [p value with Benjamini-
Hochberg correction (P
B-H
) = 6.03 × 10-3, Fig. S2]. These 20 clus-
ters included the causative genes when mutated for four different 
monogenic mental retardation disorders (ANKRD11,55 CHL1,56 
EHMT157 and VLDLR58,59) and genes implicated in complex 
traits through GWAS and CNV analyses to phenotypes such as 
behavioral and psychiatric disorders including autism and bipo-
lar disorder (ANKRD11,60 DLGAP261 and DPP1060,62); synaptic 
Figure 1. human cpG beacons by 1 kb density score and genomic location. Loci greater than or equal to a threshold of 20/kb are indicated. a telo-
meric bias in peaks is evident, as well as in the historic chromosome 2q13 fusion point.36
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eventually lead to the acquired GpCs outweighing CpGs over 
time. We calculated this via a sliding window analysis with a 
window size of 1 kb and slide of 100 bp across the genome (see 
Fig. 2). The vast majority of the extreme beacon clusters were 
genomic outliers of PBC score, i.e. EHMT1 and CDH4 and all 
except two possessed positive scores (see Table S1). These two 
extreme negative scores were identified in loci known for exten-
sive and continual gene conversion, the olfactory receptors, with 
PBC score peaks of -23/kb and -16/kb for OR2T3 and OR2T12, 
respectively.
Extreme CpG beacon clusters appear to be strongly driven by 
BGC; therefore, PBCs indicate regions where the gained CpGs 
beacons are not as hypermutable as would be expected, likely due 
to a loss of methylation in germ line. By retaining from the 20 
clusters only those with at least a +5 PBC score, more significant 
p values in both biological category enrichments of cognition and 
behavior were obtained (binomial p = 7.19 × 10-6 and 9.41 × 10-6, 
Q FDR value = 6.3 × 10-2 and 4.1 × 10-2, respectively). To explore 
the potential of this CpG beacon-specific increase genome-wide, 
we identified all the PBC ≥ +5 loci comprising 2,601 regions, that 
account for ~0.1% of the human genome. IPA analysis of associ-
ated PBC genes showed significant results for a large number of 
common disease categories (P
B-H
 < 1 × 10-20) (data not shown), 
although this result will be biased disproportionally with larger 
gene regions. Examining these PBC loci with GREAT (genomic 
regions enrichment of annotation tool) analysis, which corrects 
for this issue of potential genomic space available to input sig-
nal, we identified a number of significant results for potential 
human phenotypes and traits (see Table S3, FDR Q < 0.05), such 
as cortical gyral simplification (binomial FDR Q-value = 1.94 
rise, which is thought to be a neutral process, with a consequent 
increase in CpGs. Therefore this implies the CpG beacon clusters 
associate with a recombination driven CpG increase in human, 
as opposed to regions of high CpG mutability in other primates. 
Moreover, we also identified the majority of these clusters in telo-
meric regions (52.3% in terminal chromosome bands), which are 
known to have elevated rates of recombination in males,67 with 
hotspots associated with BGC.40 A 15% greater divergence in ter-
minal ends of chromosomes was identified in the chimpanzee 
sequencing project.8
Cohen et al. recently reclassified CGIs using evolutionary 
modeling into those that were classical hypo deaminated islands, 
with ~80% of these 10 kb from a transcription start site (TSS) and 
with strong overlap with H3K4me3, and those that had arisen as 
a by-product of BGC that were typically constitutively hyper-
methylated.41 However, on examination of the available sperm 
methylome data via MeDIP-seq,68 which includes data for 18 of 
these extreme beacon cluster regions that co-located with CGI, 
these were found to be predominately hypomethylated. The aver-
age methylation level was 26.38%, therefore aiding the retention 
of CpGs by reduced mutability, enabling potential regulation by 
methylation to occur.10
Positive CpG beacon clusters. To differentiate between spe-
cific CpG increase, as opposed to generalized regions of GC rise, 
we controlled by the concurrent formation of the exact inverse 
dinucleotide GpC; which lacks methylation ability. We defined 
Positive CpG Beacon Clusters (PBCs) as regions where CpG bea-
cons outweighed their local human-specific GpC content. BGC 
increases regional GC content and therefore passively CpGs, but 
if CpGs are methylated in the germ line their continual loss will 
Figure 2. human positive cpG beacon scores calculated across the genome in 1 kb windows with 100 bp slide. Extreme positive or negative loci are 
indicated.
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methylation in CGI across all three species in the Ensembl CGI 
set (see Fig. S7A, p < 2.2 × 10-16) and as well the Wu et al. CGIs 
that are proposed to have improved trans-species CGI prediction 
(Fig. S7B, p < 2.2 × 10-16).78
We then investigated whether the influence on methylation 
change was still apparent in CpG density that changed over time 
in orthologous CGI between these species. We identified the 
orthologous CGI set between human and chimpanzee (Ensembl 
n = 13,999, Wu et al. n = 34,053), and human and macaque 
(Ensembl n = 4,654, Wu et al. n = 19,200) and chimpanzee and 
macaque (Ensembl n = 4,004, Wu et al. n = 18,747). For exam-
ple, the orthologous DPP10 CpG beacons extreme cluster CGI, 
showed average methylation (RPM) of 0.51 and 4.80 in human 
and chimpanzee respectively, but not enough CpG density in 
macaque for a CGI to be defined even by the Wu et al. method-
ology. The subset of these orthologous islands that were ≥ 20% 
CpG density in one species and ≤ 19% in the other was then 
obtained. A significant difference was identified in the Ensembl 
set for human vs. chimpanzee CGI (Wilcoxon p = 1.954 × 10-12; 
data not shown) and in the larger Wu et al. set these group-
ings showed a small but significant reduction in methylation 
[expressed as average reads per million (RPM)] consistently in 
the higher density CGI group across all species comparisons (see 
Fig. 4, all p Wilcoxon < 2.2 × 10-16).
× 10-4), atrophy/degeneration affecting 
the central nervous system (Q = 1.69 × 
10-2), abnormality of the cerebral cor-
tex (Q = 2.23 × 10-2) and poor speech 
(Q = 4.66 × 10-2). A large number of 
biological processes were implicated 
as significant, including the nucleus 
accumbens development (Q = 6.31 × 
10-7), nose development (Q = 4.52 × 
10-6) and neurotransmitter transport 
(Q = 1.27 × 10-2) (see Table S4).
These PBCs regions were also 
enriched in intragenic islands (CGI 
within transcripts but not at the classical 
5' promoter region), being found twice 
as commonly within these regions as 
would be expected for their genomic size 
(see Fig. S3, χ2 p < 2.20 × 10-16). In fact, 
with increasing CpG beacon density this 
intragenic enrichment became stronger 
(see Fig. S4, Beacons ≥ 10, χ2 p < 2.20 
× 10-16). These islands have been impli-
cated in a number of other studies for 
their significant role in developmentally 
important isoforms.5,69,70 Examination 
of repeat classes identified enrichment 
in the hominid-specific SVA subclass71,72 
(see Fig. S5, χ2 p < 2.20 × 10-16), which 
arose ~20 MYA and has been extremely 
prolific during evolution of the primate 
genome.73,74
Correlation between CpG density 
and CGI hypomethylation. While specific genetic methylation-
determining regions (MDRs75) have been identified within CGIs, 
a correlation with CpG density and hypomethylation has also 
previously been recognized.10 Therefore, CpG beacon clusters 
will lead to species-specific CpG density increases which may be 
associated with increased CGI hypomethylation and formation 
of permissive chromatin.76 A CpG density of ~20% CpGs (or 
10% methylatable cytosines) was proposed by Eckhardt et al.19 as 
a threshold beyond which CGI are highly likely to be constitu-
tively unmethylated across all differentiated tissues. Examining 
the available data from two bisulphite sequencing experiments 
from Li et al.77 in peripheral blood cells and Lister et al.2 from 
fibroblasts, we find methylation within CGIs is strongly corre-
lated in these sets (r2 = 0.84), despite being confounded by dif-
ferent experiments, tissues and cell line effects. Furthermore, the 
same significant trend of reduced methylation when CGIs were 
categorized into subgroups of all, ≥ 15%, ≥ 20%, ≥ 25% CpG 
density is seen using both the Ensembl CGI definition and an 
alternate CGI set by Wu et al. identified via hidden Markov mod-
els.78 (Kruskal-Wallis p < 2.2 × 10-16) (Fig. 3; Fig. S6A–C).
Next, we generated peripheral blood cell methylome data 
by MeDIP-seq of pooled samples from chimpanzee and rhesus 
macaque as well as pooled human samples. Examination of these 
data also supported the inverse correlation of CpG density with 
Figure 3. cpG density influence on methylation in Wu et al. cpG Islands from Li et al. bisulphite 
methylome data from peripheral blood mononuclear cell DNa (Kruskal-Wallis rank sum test p value 
< 2.2 × 10-16).77,78
www.landesbioscience.com Epigenetics 1193
modification can lead to disparate effects depending 
on genomic location; repressive in CGI,18 activating in 
gene bodies47 and splicing influence in CTCF binding 
sites.84 Changes in developmental timing are significant 
in species-specific differences85 and the epigenetic mod-
ulation of intragenic islands may direct developmen-
tally critical isoforms.5,86 Thus, this epigenomic extra 
layer of control enables additional axes to the adaptive 
landscape and aids in the evolution of complex pheno-
types.23,87 Cytosine methylation has also been suggested 
to be significant in karyotype evolution.88 Even simply 
focusing on human higher cognitive functioning, not-
withstanding all the other phenotypic differences, levels 
of brain tissue-specific imprinting,89,90 distinctive neu-
ronal DNA methylation profiles91,92 and potential role 
in synaptic plasticity,93 as well as pathogenic Methyl 
Binding Domain gene mutations in post-natal brain 
development disorders,94,95 all postulate that the gain 
and loss of CpG may be fundamental in the human-
specific phenotype.
We therefore identified a subset of species-specific 
CpGs by inter-primate comparison, impartial to mech-
anistic cause, which we have termed CpG beacons. 
Focusing initially on extreme human CpG beacon 
clusters, we showed they are enriched for neurological 
disease genes and, additionally, co-locate with the evo-
lutionary accelerated HAR1A nc-RNA gene. A strong 
correlation between accelerated genomic loci and bias 
toward increased GC content was observed previ-
ously,35 due to the effects of recombination.30 Fine scale 
recombination hotspots show high diversity between 
human and chimpanzee, as they are short-lived relative 
to divergence times,96,97 potentially strongly influenced 
by the variation in zinc finger binding of PRDM9.98,99 
GC-coupled CpG increase due to recombination has been sug-
gested to have played a considerable role in CGI formation11 and 
thus may be a strong driver in the formation of CpG beacon clus-
ters and thus species-specific regulation.
However, on top of the localized strong effect of BGC on 
increased GC, multiple subtle substitutions have been shown 
to have a morphological evolution effect altering the timing 
and level of expression.100 We looked for potential CpG-specific 
signatures by identifying where human-specific CpG exceeded 
human-specific GpC, defining Positive CpG Beacon Clusters, 
which identified potential human traits that may have arisen dur-
ing human evolution.101
Recent comparative methylome analyses have revealed species-
specific differences.102,103 Molaro et al. examined chimpanzee and 
human sperm and supported the link between genome and epig-
enome, by identifying strong CpG decay correlated with meth-
ylation over brief evolutionary periods. They also found extensive 
species-specific methylation differences in SVA repeats, with 
significantly increased numbers of orthologous hypomethylated 
SVAs within humans. Interestingly, this is the same subtype in 
which we identified high enrichment of positive beacon clusters, 
which could be driving this hypomethylation. Additionally SVAs 
Therefore, we have shown that varying CpG density changes 
the methylation potential within CGIs. This change in likeli-
hood of methylation between low and high density CGIs was 
found to occur across and between the three species. The most 
extreme human-specific genomic eruptions of CpGs occur in the 
identified “CpG beacon” clusters, which in turn have highlighted 
genes associated with human traits and disease.
Discussion
The proteome is similar across placental mammals; therefore, 
the creation of new protein coding genes is rare,79 although not 
unknown.80 Regulatory modification has long been proposed as 
critical in human acquired traits66 and genomic data acquired 
in the last decade supports the hypothesis that species evolu-
tion is predominately via novel regulatory adaptation and sub-
sequent altered gene expression.79,81 Recently, the identification 
of human-specific loss of regulatory DNA revealed insights into 
human evolutionary divergence.82
Epigenetic mechanisms, including DNA methylation, are 
critical in genome regulation and viable mammalian develop-
ment requires the ability to methylate cytosines.83 This chemical 
Figure 4. comparison of methylation in subset of orthologous cGI set from Wu et 
al.78 The RpM in these islands was compared by subtraction. First human[RpM] – 
chimpanzee[RpM], in islands human (hs) > 20% cpG and chimpanzee (pt) < 19% 
cpG then chimpanzee > 20% cpG and human < 19% cpG. Then human[RpM] 
– Macaque[RpM], human (hs) > 20% cpG and Macaque (Mm) < 19% cpG and Ma-
caque > 20% cpG and human < 19% cpG. Finally chimpanzee [RpM] – Macaque 
[RpM] in islands chimpanzee > 20% cpG and Macaque < 19% cpG then Macaque 
> 20% cpG and chimpanzee < 19% cpG. all show a consistent pattern where the 
less cpG dense island (< 19%) is more methylated than the more cpG dense island 
(> 20%).
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In conclusion, the CpG dinucleotide is vital for regulation 
and not only transmits genomic data but also enables epigenomic 
variation. Thus, genomic change in this dynamic dinucleotide 
required for DNA methylation, influencing CGI methylation, 
gene body methylation, imprinting and splicing, is fundamental 
to understanding our evolutionary acquired traits and vulner-
abilities to disease.
Methods
CpG beacon identification. CpG loss is time- not replication-
dependent; therefore, there are almost equal counts of CpG in 
human and chimpanzee.43 Recent estimates from whole genome 
sequencing for mutation rate is ~1 × 10-8 per generation105 with 
the CpG dinucleotide approximately ten times this. Due to the 
rapid turnover in regulatory elements,106 most are too weakly 
conserved to mouse to distinguish45 which will particularly be 
the case with the highly mutable CpGs. By utilizing the additive 
collective divergence of multiple primates44,45 a CpG’s human-
specific state was attributed. The comparatively inferior sequence 
quality of these individual non-human primate sequences was 
balanced by the combined multispecies comparison vs. human. 
Assignment of ancestral state by use of chimpanzee alone was 
found to have an error rate of 0.65% utilizing macaque as a 
have recently been identified to be involved in active somatic ret-
rotranspositon in human brain.104
Lienart et al. have recently identified the existence of 
methylation-determining regions (MDRs) due to sequence char-
acteristics within CGI, but also acknowledged the necessity of 
a critical CpG density within these regions.75 Increasing CpG 
density forms low density CpG islands which are more likely 
to have variable methylation and hence to be tissue-specific or 
developmental time-dependent. Further density rise will create 
high density islands that eventually will become increasingly 
likely to become constitutively hypomethylated above a thresh-
old identified earlier by Eckhardt et al.19 This correlation can be 
seen by re-examination of the Li et al.77 and Lister et al.2 bisul-
phite sequencing data and is supported across three species in 
this study via MeDIP-seq. Either MDR-induced CpG retention, 
BGC created CpGs, or potentially both can lead to clusters of 
CpGs resulting in hypomethylated islands that then recruit fac-
tors such as Cfp1. While this process does not lead to explicit 
expression per se, it establishes open permissive chromatin via 
H3K4me3 marked domains.12,76 Therefore, CpG beacons have 
the capacity to move, or indicate the movement of, these loci 
along a continuum from no island to tissue-specific island to 
constitutively active island, as illustrated in the model shown in 
Figure 5.
Figure 5. Model for beacon-mediated cGI evolution and example for possible association with disease. The left panel illustrates a model for cpG 
beacon-mediated increase of cpG density. a moderate cpG beacon increase lead to the formation of low density cGIs which are predominantly 
methylated and prone to tissue-specific methylation. Further cpG beacon increase can eventually lead to high density cGIs with increased likelihood 
of becoming constitutively hypomethylated. Variation in such cGIs could then result in species-specific phenotypic changes as discussed in this study 
for cGIs containing extreme clusters of > 20 beacons per kb. cpG beacon gain may indicate reduced mutability due to acquisition of new methylation 
determining regions,75 direct gain due to accumulated substitution or biased gene conversion, or a combination of all of these processes. The right 
panel shows an example of one of the identified extreme cpG beacon cluster containing cGIs that is associated with the human ANKRD11 gene, impli-
cated in autism. In this case, the cpG density and methylation state of the orthologous cGIs in human, chimpanzee and macaque are concordant with 
the proposed model. Methylation values were determined by MeDIp-seq and are given as reads per million (RpM).
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Gene set enrichment analyses. Ingenuity Pathway Analysis 
©IPA was performed for gene set enrichment. The location of 
clusters was assigned to genes if it mapped to within 100k 5' and 
50k 3' of the transcript. The following IPA analysis settings were 
used: Reference set: Ingenuity Knowledge Base (Genes Only), 
Relationship to include: Direct and Indirect, Includes Endogenous 
Chemicals. Optional Analyses: My Pathways My List. Filter 
Summary: Consider only molecules and/or relationships 
where (species = Human) AND (confidence = Experimentally 
Observed). Benjamini-Hochberg multiple test corrected p values 
are shown only. The region-based binomial analysis of GREAT 
analysis 2.0.165 was utilized to identify genome regional enrich-
ments from the location of the extreme beacon clusters, as well 
as the moderate positive beacons clusters ≥ 5. This takes into 
consideration the bias of potential genomic space available com-
pared with the traditional hypergeometric test. The parameters 
used were association by Basal plus extension with default values 
of proximal 5 kb upstream, 1 kb downstream, but a reduced dis-
tal limit to 100 kb from 1 Mb and significance assessed by the 
regional based Binomial test FDR Q value.
Publicly available bisulphite sequencing data. The Lister 
et al. fibroblast methylome data was downloaded from http://
neomorph.salk.edu/human_methylome/data.html. The Li et al. 
PBMC methylome data was downloaded from the NCBI Gene 
Expression Omnibus (www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc = GSE17972). For the Lister et al. and Li et al. data sets 
individual CpG methylation was calculated by combining the 
reads from the two strands and subsequently requiring a five read 
minimum coverage for inclusion.
Comparative MeDIP-seq. DNA was extracted from periph-
eral blood of five chimpanzees (Pan troglodytes, three males, 
two females) and five rhesus macaques (Macaca mulatta, three 
males, two females). Samples were taken from captive individu-
als at Tierpark Nordhorn, Basel Zoo, Leipzig Zoo and at the 
German Primate Center during routine health checks and not 
specifically for this study. Microsatellite analysis conducted at the 
German Primate Center verified that respective individuals are 
not related. Sample collection adhered to the American Society 
of Primatologists (ASP) Principles for the Ethical Treatment 
of Non-Human Primates (www.asp.org/society/resolutions/
EthicalTreatmentOfNonHumanPrimates.cfm).
To obtain averaged methylomes and reduce individual geno-
type effects, DNAs were pooled for each species at equal concen-
tration for each individual. MeDIP was then executed according 
to Auto-MeDIP-seq protocol as described previously110 and 
sequenced on Illumina GAIIx. This was performed with paired 
end reads of 36 bp with average fragment sizes of: 197 bp in 
human, 222 bp in chimpanzee, and 217 bp in macaque. The 
corresponding methylome data are available from the authors 
on request. A comprehensive analysis of these methylomes 
will be described elsewhere (Wilson G.A. et al., manuscript in 
preparation).
second out-group.107 Furthermore, most SNPs have been calcu-
lated to be < 1 million years of age, compared with the minimum 
divergence time of chimpanzee and human which is estimated at 
5 million years.108
Therefore, to identify the human-specific changes we utilized 
the Ensembl Compara.6_primates_EPO six primates align-
ment51,52 build 58. This includes the species Homo sapiens, Pan 
troglodytes, Gorilla gorilla, Pongo abelii, Macaca mulatta and 
Callithrix jacchus. The builds included are human GRCh37, chim-
panzee Mar. 2006 (CGSC 2.1/pan Trog2), gorilla (gorGor3); 
orang-utan Jul 2007 (WUSTL version Pongo_albelii-2.0.2); 
macaque Jan 2006 (MGSC Merged 1.0/rheMac2); and mar-
moset Mar 2009 (WUGSC 3.2 (GCA_000004665.1)). The 
Ensembl Compara.6_primates_EPO alignment blocks was then 
reduced in a stepwise fashion due to the requirement of: unique 
human sequence, i.e. does not align to greater than one loca-
tion in human genome (82.71% of human genome remaining); 
unique chimpanzee sequence (80.54%); and contains at least 
one other primate (79.99%) in order to utilize the strength of 
the inter-primate comparison.45 Within this ~80% of the human 
genome that was able to be aligned, an algorithm was devised 
to identify the location of each human CpG site within these 
blocks and then compared with the corresponding bases in other 
species. To be identified as a potential human-specific CpG, the 
requirement in chimpanzee sequence was that it did not match 
CG and did not contain N or –. All other species sequences at 
this position also did not match CpG and the closest other pri-
mate (gorilla in 96.64% of sites) did not contain N or –. If this 
was the case then it was recorded as a human-specific CpG site, 
which led to a set of 1,820,319 CpGs. All human cluster locations 
are given in build Human GRCh37 coordinates. The chimpan-
zee beacons were calculated using the exact same methodological 
algorithm as the human, but instead changing the focused spe-
cies to Pan troglodytes.
Polymorphic filter. Any CpG with evidence of polymor-
phism from 1,000 Genomes data for SNP, CNV and Indel was 
then removed from the set. The December 2010 Data update 
Full Project Genotype Release from calls on 629 individuals 
from the 20100804 sequence was used. Indel data was from 
the February 2011 update, which were calls from Dindel on the 
same 629 individuals from the 20100804 sequence and align-
ment, and also available CNV data from 179 unrelated indi-
viduals.109 This resulted in a non-polymorphic human set of 
1,192,484 CpGs.
CpG beacon density calculation and permutations. Initial 
density permutations were calculated for each CpG beacon by 
counting the number of CpG beacons within a region of 499 bp 
downstream and 500 bp upstream. Random beacon sets of the 
same number 1,192,484 were generated from the total set of loca-
tions of CpGs in the h1c1o1 genome set of 20,207,732 and den-
sity calculated.
Positive CpG beacon clusters. Positive beacon clusters were 
calculated, via a sliding window of 1 kb and slide of 100 bases 
across the genome. The total non-polymorphic human-specific 
GpCs within the 1kb region was subtracted from the total CpG 
beacons within this region.
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= 118, Wu = 1451 (Hs, Homo sapiens; Pt, Pan troglodytes; Mm, 
Macaca mulata).
Statistical analysis. Statistical calculations were performed 
in the R statistical environment.117 Empirical p values were cal-
culated as the excess of simulation vs. observed values. Kruskal-
Wallis rank sum test was used to compare methylation in CGI 
density sets and Wilcoxon test for comparison between average 
RPM values for orthologous island sets. Chi-square calcula-
tions for enrichments were performed for PBC by bases covered 
of PBC vs. total bases of category and CpG beacon vs. total 
CpGs.
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MeDIP-seq data was processed using MeDUSA (methylated 
DNA utility for sequence analysis).111 This computational pipeline 
performs a full analysis of MeDIP-seq data by utilizing a number 
of freely available software packages. Raw sequence data in fastq 
format were aligned to the reference genomes (Human GRCh37, 
panTro2 and rheMac2) using alignment software BWA (v0.5.8),112 
with default parameters, to generate a SAM format alignment file. 
Aligned reads were filtered using SAMtools (v0.1.9)113 to remove 
reads that failed to form a correctly aligned pair (forward and 
reverse templates). Further filtering based on mapping score was 
also performed (read pair must contain read with mapping quality 
≥ 10). Potential PCR artifacts were removed by discarding all but 
one read within groups of non-unique reads (i.e., reads aligned 
to the exact same start and stop position on the same chromo-
some). FastQC (www.bioinformatics.bbsrc.ac.uk/projects/fastqc) 
was used to determine sequence data was of acceptable quality 
and the Bioconductor (v2.7)114 package MEDIPS (v1.0.0)115 per-
formed enrichment and coverage analyses. Reads per million 
(RPM) was calculated within regions as (reads/total reads) times 
106 for each species (total human reads = 40,797,356, chimpanzee 
= 32,910,189 and macaque = 24,933,164).
Genetic influence on the DNA methylome. The MEDIPS 
package was used to approximate absolute methylation scores 
from relative MeDIP results.115 This enables regional methyla-
tion to be compared over features, i.e., CpG Islands utilizing the 
appropriate genome sequence for each species. LiftOver116 was 
used to calculate orthologous CGI sets with overlap of at least 
95% required. Greater than 20% and less than 19% orthologous 
sets were chosen from the orthologous island sets for each group-
ing with the following numbers: Hs ≥ 20 and Pt ≤ 19, Ensembl 
= 375, Wu = 557; Pt ≥ 20 and Hs ≤ 19, Ensembl = 150, Wu = 
614; Hs ≥ 20 and Mm ≤ 19, Ensembl = 248, Wu = 605; Mm ≥ 
20 and Hs ≤ 19 Ensembl = 62, Wu = 1530; Pt ≥ 20 and Mm ≤ 
19, Ensembl = 256, Wu = 700; Mm ≥ 20 and Pt ≤ 19 Ensembl 
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